David Rosenbaum - May 20, 2022 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Stock symbol
ARDX
Transactions as of
May 20, 2022
Transactions value $
-$1,352
Form type
4
Date filed
5/23/2022, 04:37 PM
Previous filing
Feb 25, 2022
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Sale -$1K -1.49K -0.43% $0.67* 348K May 20, 2022 Direct F1
transaction ARDX Common Stock Sale -$352 -524 -0.49% $0.67* 108K May 20, 2022 By Wife F1, F2, F3
holding ARDX Common Stock 77.6K May 20, 2022 Family Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
F2 Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2022.
F3 The shares are directly held by the Reporting Person's wife.
F4 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.